m****g
发帖数: 530 | 1 SAN ANTONIO (April 1, 2010) — If research results continue to be repeated
and are turned into clinical
trials, a drug already approved for some uses could be marshaled — sooner
than we expect — to prevent
Alzheimer's disease in humans and improve health to the end of life.
A few weeks after a report that rapamycin, a drug that extends lifespan in
mice and that is currently used
in transplant patients, curbed the effects of Alzheimer's disease in mice, a
second group is announcing
similar results |
|
